产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF8333, RRID:AB_2840395.
展开/折叠
Deubiquitinating enzyme 28; KIAA1515; Ubiquitin carboxyl terminal hydrolase 28; Ubiquitin carboxyl-terminal hydrolase 28; ubiquitin carboxyl-terminal hydrolase 28 variant 1; Ubiquitin specific peptidase 28; Ubiquitin specific processing protease 28; Ubiquitin specific protease 28; Ubiquitin thioesterase 28; Ubiquitin thiolesterase 28; Ubiquitin-specific-processing protease 28; UBP28_HUMAN; USP 28; USP28; USP28 protein;
抗原和靶标
- Q96RU2 UBP28_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MTAELQQDDAAGAADGHGSSCQMLLNQLREITGIQDPSFLHEALKASNGDITQAVSLLTDERVKEPSQDTVATEPSEVEGSAANKEVLAKVIDLTHDNKDDLQAAIALSLLESPKIQADGRDLNRMHEATSAETKRSKRKRCEVWGENPNPNDWRRVDGWPVGLKNVGNTCWFSAVIQSLFQLPEFRRLVLSYSLPQNVLENCRSHTEKRNIMFMQELQYLFALMMGSNRKFVDPSAALDLLKGAFRSSEEQQQDVSEFTHKLLDWLEDAFQLAVNVNSPRNKSENPMVQLFYGTFLTEGVREGKPFCNNETFGQYPLQVNGYRNLDECLEGAMVEGDVELLPSDHSVKYGQERWFTKLPPVLTFELSRFEFNQSLGQPEKIHNKLEFPQIIYMDRYMYRSKELIRNKRECIRKLKEEIKILQQKLERYVKYGSGPARFPLPDMLKYVIEFASTKPASESCPPESDTHMTLPLSSVHCSVSDQTSKESTSTESSSQDVESTFSSPEDSLPKSKPLTSSRSSMEMPSQPAPRTVTDEEINFVKTCLQRWRSEIEQDIQDLKTCIASTTQTIEQMYCDPLLRQVPYRLHAVLVHEGQANAGHYWAYIYNQPRQSWLKYNDISVTESSWEEVERDSYGGLRNVSAYCLMYINDKLPYFNAEAAPTESDQMSEVEALSVELKHYIQEDNWRFEQEVEEWEEEQSCKIPQMESSTNSSSQDYSTSQEPSVASSHGVRCLSSEHAVIVKEQTAQAIANTARAYEKSGVEAALSEVMLSPAMQGVILAIAKARQTFDRDGSEAGLIKAFHEEYSRLYQLAKETPTSHSDPRLQHVLVYFFQNEAPKRVVERTLLEQFADKNLSYDERSISIMKVAQAKLKEIGPDDMNMEEYKKWHEDYSLFRKVSVYLLTGLELYQKGKYQEALSYLVYAYQSNAALLMKGPRRGVKESVIALYRRKCLLELNAKAASLFETNDDHSVTEGINVMNELIIPCIHLIINNDISKDDLDAIEVMRNHWCSYLGQDIAENLQLCLGEFLPRLLDPSAEIIVLKEPPTIRPNSPYDLCSRFAAVMESIQGVSTVTVK
翻译修饰 - Q96RU2 作为底物
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| K45 | Ubiquitination | Uniprot | |
| K64 | Ubiquitination | Uniprot | |
| S67 | Phosphorylation | Q13315 (ATM) | Uniprot |
| T70 | Phosphorylation | Uniprot | |
| K85 | Ubiquitination | Uniprot | |
| K90 | Ubiquitination | Uniprot | |
| K99 | Sumoylation | Uniprot | |
| S113 | Phosphorylation | Uniprot | |
| T130 | Phosphorylation | Uniprot | |
| S131 | Phosphorylation | Uniprot | |
| T134 | Phosphorylation | Uniprot | |
| K243 | Ubiquitination | Uniprot | |
| S279 | Phosphorylation | Uniprot | |
| S375 | Phosphorylation | Uniprot | |
| K381 | Ubiquitination | Uniprot | |
| K420 | Ubiquitination | Uniprot | |
| K425 | Ubiquitination | Uniprot | |
| K431 | Ubiquitination | Uniprot | |
| Y447 | Phosphorylation | Uniprot | |
| S493 | Phosphorylation | Uniprot | |
| S495 | Phosphorylation | Q13315 (ATM) | Uniprot |
| S503 | Phosphorylation | Uniprot | |
| S504 | Phosphorylation | Uniprot | |
| K513 | Ubiquitination | Uniprot | |
| S520 | Phosphorylation | Uniprot | |
| S521 | Phosphorylation | Uniprot | |
| K542 | Ubiquitination | Uniprot | |
| T543 | Phosphorylation | Uniprot | |
| S550 | Phosphorylation | Uniprot | |
| Y654 | Phosphorylation | Uniprot | |
| S714 | Phosphorylation | Q13315 (ATM) | Uniprot |
| S720 | Phosphorylation | Q13315 (ATM) | Uniprot |
| T753 | Phosphorylation | Uniprot | |
| T788 | Phosphorylation | Uniprot | |
| K839 | Ubiquitination | Uniprot | |
| K853 | Ubiquitination | Uniprot | |
| K897 | Ubiquitination | Uniprot | |
| Y901 | Phosphorylation | Uniprot | |
| T1048 | Phosphorylation | Uniprot | |
| S1053 | Phosphorylation | Uniprot | |
| S1059 | Phosphorylation | Uniprot |
研究背景
Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus. Deubiquitinates ZNF304, hence preventing ZNF304 degradation by the proteasome and leading to the activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) in a subset of colorectal cancers (CRC) cells.
Degraded upon nickel ion level or hypoxia exposure.
Phosphorylated upon DNA damage at Ser-67 and Ser-714, by ATM or ATR. Phosphorylated by PRKD1.
Nucleus>Nucleoplasm.
Interacts with ZNF304. Interacts with PRKD1. Interacts with TP53BP1. Interacts with isoform 1 of FBXW7; following DNA damage, dissociates from FBXW7 leading to degradation of MYC.
Belongs to the peptidase C19 family. USP28 subfamily.
限制条款
产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.